.RESEARCH HIGHLIGHT.06 August 2024.
A large randomized controlled test with cisgender ladies highlights the difficulties of fidelity to a daily oral preexposure prophylaxis routine and also shows that twice-yearly shot of lenacapavir may maintain efficient HIV protection levels over 6 months.